arrow
A

Alessandro Re

asst spedali civili di brescia
H指数:39
被引数:5,906

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Role of direct-acting antivirals in people with HIV-associated non-Hodgkin lymphoma and concomitant HCV infection: A study on behalf of the Fondazione Italiana Linfomi

直接抗病毒药物在合并HCV感染的HIV相关非霍奇金淋巴瘤患者中的作用:意大利淋巴瘤基金会研究

2026-09-060
PRE
Secondary Genetic Events and Their Relationship to TP53 Mutation in Mantle Cell Lymphoma: A Sub-Study from the FIL_MANTLE-FIRST BIO on Behalf of Fondazione Italiana Linfomi (FIL)

次级遗传事件及其与Mantle Cell Lymphoma中TP53突变的关系:一项来自FIL_MANTLE-FIRST BIO的亚组研究,代表意大利淋巴瘤基金会(FIL)

Cancers
IF4.4
2026-03-040
OAAI
Letter in response to “Overcoming barriers to referral for CAR T-cell therapy in patients with non-Hodgkin aggressive B-cell lymphomas: A Delphi Consensus”

致“克服非霍奇金侵袭性B细胞淋巴瘤患者CAR T细胞疗法转诊障碍:德尔菲共识”一文的函

2025-09-260
PRE
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study

利妥昔单抗、 bendamustine 和 cytarabine,随后使用 venetoclax 治疗高风险套细胞淋巴瘤老年患者(FIL_V-RBAC):一项多中心、单臂、Ⅱ期研究

2025-09-170
PRE
Long-term results of the FIL MCL0208 trial of lenalidomide maintenance versus observation after ASCT in MCL patients

FIL MCL0208试验中,来那度胺维持治疗与观察在MCL患者自体干细胞移植(ASCT)后的长期结果

2025-03-220
OAAI
Long-Term Clinical Outcomes After Autologous Hematopoietic Stem Cell Transplantation in 49 Individuals Living With HIV (PLWH) and Affected by High-Risk or Relapsed Lymphoma: A European Experience of Continued Relevance for PLWH

自体造血干细胞移植后49例人类免疫缺陷病毒感染者(PLWH)且伴有高危或复发性淋巴瘤的长期临床结局:一项对PLWH持续相关性的欧洲经验

2025-01-150
PRE
Minimal Residual Disease Evaluation in the Context of V-Rbac, a Risk-Tailored Phase II Trial of the Fondazione Italiana Linfomi (FIL)

V-Rbac背景下微小残留病评估,一项Fondazione Italiana Linfomi (FIL)风险定制II期临床试验

BLOOD
IF23.1
2024-11-050
PRE
Human immunodeficiency virus-associated Lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2024-09-030
OAAI
Intranasal administration of Escherichia coli Nissle expressing the spike protein of SARS-CoV-2 induces long-term immunization and prevents spike protein-mediated lung injury in mice

鼻腔给药表达SARS-CoV-2刺突蛋白的大肠杆菌Nissle诱导小鼠长期预防接种并防止刺突蛋白介导的肺损伤

2024-05-010
OAAI
MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective study

HIV相关大b细胞淋巴瘤中的MYC重排: 欧洲回顾性研究EUROMYC

2024-02-162
OAAI
Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL
2023-07-278
OAAI
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial
2023-07-181
OAAI
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi
2023-04-014
OAAI
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review
2023-01-207
OAAI
Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study
LEUKEMIA
IF13.4
2023-01-1818
OAAI
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL)
2022-11-1713
OAAI